2.The in vitro inhibitory effects of oridonin on proliferation of conjunctival fibroblasts after trabeculectomy in rabbit
Jianming WANG ; Na HUI ; Yazhi FAN ; Lei XIONG ; Naixue SUN
Ophthalmology in China 1994;0(02):-
Objective To investigate inhibitory effects of Oridonin on the proliferation of cultured rabbit conjunctival fibroblast (RCF). Design Experimental study. Participants Cultured RCF obtained from filtering area after trabeculectomy. Methods Trabeculectomy was performed in rabbits. On day 7 after surgery, subconjunctival tissue from filtering area was obtained for culturing RCF in vitro. Cultured RCFs were exposed to different concentration Oridonin (5, 10, 20, 30, 40, and 50 ?mol?L-1) for 48h, respectively. The proliferation of RCF was investigated by MTT assay at different time points. Main Outcome Measures Optical density (OD) value of RCF and inhibitory rate of cell growth. Results OD values of each concentration Oridonin group (5, 10, 20, 30, 40, and 50 ?mol?L-1) were (0.402?0.013), (0.347?0.011), (0.293?0.015), (0.236?0.022), (0.184?0.023), and (0.125?0.014), respectively. These data showed a significant difference compared with the OD value (0.453?0.015) of control group without Oridonin (P=0.021-0.000). The inhibitory effects showed a significant difference in a dose-dependent manner (F=5.48, P=0.003). Oridonin (5, 10, 20, 30, 40 and 50 ?mol?L-1) sup-pressed the proliferation of RCF in vitro at rates of 11.26%, 23.40%, 35.32%, 47.90%, 59.38% and 72.41%, respectively. Conclusion Oridonin can inhibit the proliferation of cultured RCF obtained from filtering area. The effect is in a dose-dependent manner. This indicates that Oridonin is most likely to be a novel agent to prevent excessive scarring following glaucoma surgery.
3.Dosimetric verification of volumetric modulated arc therapy in nasopharyngeal carcinoma using COMPASS 3D patient anatomy based system
Penggang BAI ; Qixin LI ; Kaiqiang CHEN ; Xiuchun ZHANG ; Yazhi WANG ; Xingwu HUANG
Chinese Journal of Radiological Medicine and Protection 2012;32(3):304-307
Objective To investigate the dosimetric performance of COMPASS system,a novel 3D quality assurance system for the verification of nasopharyngeal carcinoma volumetric modulated therapy (VMAT) treatment plan.Methods Eight VMAT treatment plans of nasopharyngeal carcinoma patients were performed with MasterPlan,a treatment planning system (TPS),and then these treatment plans were sent to the COMPASS and MOSAIQ system,a coherent control system,respectively.Comparison of the COMPASS reconstructed dose versus TPS dose was conducted by using the dose volume-based indices:dose received by 95% volume of target ( D95% ),mean dose ( Dmean ) and γ pass rate,dose to the 1% of the spinal cord and brain stem volume ( D1% ),mean dose of leaf and right parotid ( Dmean ),and the volume received 30 Gy for left and right parotid (V30).COMPASS can reconstruct dose with the real measured delivery fluence after detector commissioning.Results The average dose difference for the target volumes was within 1%,the difference for D95 was within 3% for most treatment plans,and the γ pass rate was higher than 95% for all target volumes.The average differences for the D1% values of spinal cord and brain stem were ( 4.3 ± 3.0) % and ( 5.9± 2.9 ) % respectively,and the average differences for the Dmean values of spinal cord and brain stem were ( 5.3 ± 3.0 ) % and ( 8.0 ± 3.5 ) % respectively.In general the COMPASS measured doses were all smaller than the TPS calculated doses for these two organs.The average differences of the Dmean values of the left and right parotids were( 6.1± 3.1 ) % and ( 4.7 ± 4.4 ) % respectively,and the average differences of the V30 values of the left and right parotids were (9.4 ± 7.5 ) % and (9.4 ± 9.9)% respectively.Conclusions An ideal tool for the VMAT verification,the patient anatomy based COMPASS 3D dose verification system can check the dose difference between the real delivery and TPS calculation directly for each individual organ,either target volumes or critical organs.
4.Characteristics and influencing factors of emotional face recognition on Methamphetamine depend-ence adolescents
Lushi JING ; Yazhi WANG ; Ruili FAN ; Min ZHANG ; Zhengjun WU ; Tao JU ; Binbin WU
Chinese Journal of Behavioral Medicine and Brain Science 2019;28(5):443-447
Objective To explore the characteristics and influencing factors of methamphetamine dependence adolescents’ emotional faces recognition ability. Methods Eighty-six adolescents methamphet-amine addicts and 85 healthy volunteers were tested by a self-designed questionnaire and an experiment of e-motional faces identification. Results (1)There was no significant correlation between the emotional faces recognition ability of the experimental group with their age,education level and drug time (P>0. 05). (2)The correct number of positive(32. 58 ±8. 56),neutral (32. 76±8. 06),and negative(56. 28±20. 04) emotional faces recognition in the experimental group was significantly lower than that in the control group of positive (35. 64±3. 91),neutral(35. 47±4. 00),and negative(71. 02±8. 62) emotional faces recognition(t=-3. 00,-2. 79,-6. 24,P<0. 05). Meanwhile,the response time of positive(( 401. 32± 175. 13) ms) and negative ((502. 08±194. 42)ms) emotional faces recognition in the experimental group was significantly lower than that in the control group of positive((300. 83±139. 48)ms) and negative((379. 91±197. 30)ms) emotional faces (t=4. 15,4. 08,P<0. 05). Nevertheless,there was no significant difference between the experimental group((400. 90±174. 21) ms) and the control group ((356. 67±156. 70) ms) in the recognition response time of neutral emotional faces (t=1. 75,P>0. 05). Conclusion Methamphetamine dependence impairs the ability of adolescents’ emotional faces recognition,and their positive and negative emotional recognition abili-ty has processing defects. The ability of methamphetamine dependence adolescents to emotional faces recogni- tion is not affected by their age,education level and time of drug uses.
5.Clinical analysis of non-ketotic hyperglycemia chorea
Jianfeng QU ; Yazhi WANG ; Yonglin LIU ; Yangkun CHEN ; Weimin XIAO
Chinese Journal of Nervous and Mental Diseases 2017;43(8):496-499
Objective To investigate the clinical manifestation,neuroimaging characteristics and follow-up results of chorea associated with non-ketotic hyperglycemia (C-H-BG).Methods Clinical data of six patients with C-H-BG were analyzed retrospectively.Results The average age of the six patients (five female and one male) was 65.8±13.9 years,All patients had acute-subacute course.Patients presented with choreic movements involving facial muscles (n=6) and unilateral (n=5) or bilateral limbs (n=1).The average value of plasma glucose at admission was 9.21 ± 5.15 mmol/L.All patients had significantly elevated HbA1c (14.1 ±3.5%).The brain MRI T1 imaging from all patients showed hyperintensity in the basal ganglia,putamen,lenticular nucleus and caudate nucleus.SWI imaging revealed corresponding hypointensity signal in the basal ganglia in three patients.Two patients had severe stenosis of the MCA.Five patients were followed up for an average of 16.2 ±7.2 months.Three patients died.Conclusion The high T1 hypertense lesions in the basal ganglia are the mainly radiological feature of C-H-BG which may be accompanied by SWI hytointense signals in the basal ganglia.
6.Inhibitory effect of ILK-siRNA-AAV on scar formation after glaucoma filtering surgery in rats
Yao XING ; Jianming WANG ; Yazhi FAN ; Lei XIONG ; Wenjing WANG ; Lijun CUI
Chinese Journal of Experimental Ophthalmology 2022;40(4):316-325
Objective:To investigate the role of integrin-linked kinase (ILK)-small interfering RNA (siRNA)-adeno-associated virus (AAV) in scar formation after glaucoma filtering surgery in rat eyes.Methods:Forty-eight Sprague Dawley rats of SPF grade, aged 8 to 9 weeks old, were selected and divided into blank control group, ILK-siRNA-AAV group, NC-siRNA-AAV group and mitomycin C (MMC) group by random number table method, with 12 rats in each group.Left eyes of the rats were taken as experimental eyes, and no intervention was administered to fellow eyes.The bulbar conjunctival filtering bleb after glaucoma filtration surgery in rats was established by anterior chamber drainage tube implantation.One day after operation, phosphate buffer solution, ILK-siRNA-AAV, and NC-siRNA-AAV were injected into the filtering bleb of blank control group, ILK-siRNA-AAV group and NC-siRNA-AAV group, 5 μl each group, respectively.Cotton tablets containing 0.4 mg/ml MMC were placed under conjunctival flap for 5 minutes during operation in MMC group.Intraocular pressure (IOP) was measured with a handheld tonometer before surgery and at 1, 2, 3, 7, 14, 21, 28 days after surgery.Formation of filtering blebs in rats was observed with a surgical microscope at 1, 2, 3, 7, 14, 21, 28 days after operation, and the bleb survival time was calculated by Kaplan-Meier survival analysis.The mRNA and protein expression levels of ILK in conjunctival and subconjunctival tissues at the surgical sites were detected by reverse transcription PCR and Western blot, respectively, on the 28th day after operation.Silencing of ILK gene was identified.Effect of ILK gene silencing on the morphology of drainage pathway was observed by hematoxylin-eosin staining.Effect of ILK gene silencing on collagen fiber deposition in the bulbar conjunctiva at filtration area was examined by Masson staining, and the percentage of positive area of collagen fiber staining in the total tissue visual field was calculated.The use and care of the animals complied with the ARVO Statement.This research protocol was approved by an Ethics Committee of Xi'an Jiaotong University (No.2013-772). Results:There were statistically significant differences in IOP at different time points between before and after surgery among four groups ( Fgroup=76.84, P<0.001; Ftime=114.49, P<0.001). The IOP of ILK-siRNA-AAV group on the 1st, 7th, 14th and 28th day after operation and the IOP of MMC group on the 2nd, 3rd, 7th, 14th and 28th day after operation were lower than those of blank control group, and the differences were statistically significant (all at P<0.05). The IOP of ILK-siRNA-AAV group was lower on 7th, 14th, 21st and 28th day after operation than those of NC-siRNA-AAV group, with statistically significant differences (all at P<0.05). The bleb survival time of blank control group, NC-siRNA-AAV group, ILK-siRNA-AAV group and MMC group was (3.50±1.51), (5.00±3.41), (31.50±3.15) and (31.33±2.46) days, respectively, with a significant difference among them ( F=395.83, P<0.05). The bleb survival time of ILK-siRNA-AAV group and MMC group was higher than that of blank control group and NC-siRNA-AAV group, and the differences were statistically significant (all at P<0.05). There were statistically significant differences in the relative expression levels of ILK mRNA and protein among four groups ( F=222.32, 752.69; both at P<0.05), and the relative expression levels of ILK mRNA and protein were significantly lower in ILK-siRNA-AAV group than blank control group and NC-siRNA-AAV group, and the differences were statistically significant (all at P<0.05). Proliferative fibrous connective tissue and a large number of cells at surgical sites were found in blank control group and NC-siRNA-AAV group, and the fibroblasts were of a high density and grew in clumps.In ILK-siRNA-AAV group, the bulbar conjunctiva was thin, and the arrangement of fibrous connective tissue was loose, and a few proliferative fibroblasts were found.In MMC group, the conjunctival fibrous layer was loose and thin, forming cavities, and scarce cells were found.There was statistically significant difference in the percentage of collagen fiber positive staining area among four groups ( F=741.66, P<0.05). The positive staining percentage of ILK-siRNA-AAV group and MMC group was significantly lower than that of blank control group, among which there was lower positive staining percentage in ILK-siRNA-AAV group than NC-siRNA-AAV group, and the differences were statistically significant (all at P<0.05). Conclusions:Silencing of ILK can inhibit the scar formation after glaucoma filtering surgery and maintain low IOP in rats.
7.Study on the intestinal absorption characteristics of saikosaponins
Yazhi WANG ; Qiyi WANG ; Wenzhong FENG ; Shuangshuang CHEN ; Xinguang SUN ; Lijuan ZHOU ; Yan ZHANG ; Jianyong ZHANG ; Cancan DUAN
China Pharmacy 2023;34(14):1681-1685
OBJECTIVE To explore the intestinal absorption characteristics of saikosaponins. METHODS Based on everted intestinal sac model, using accumulative absorption amount (Q) and absorption rate constant (Ka) as indexes, UHPLC-MS/MS technique as a method, the absorption of saikosaponin A, B2, C, D and F from total saponins of Bupleurum chinense (8 g/mL, by crude drug) in the duodenum, jejunum and ileum was detected. RESULTS The correlation coefficients (r) of the regression equations for the absorption of saikosaponins A, B2, C and F in the duodenum, jejunum and ileum were all higher than 0.95, while the r of saikosaponin D in the above intestinal segments was lower than 0.95; compared with the absorption of the same composition in the duodenum, the Q and Ka of saikosaponin A and C circulating in jejunum and ileum for 120 min, as well as the Q and Ka of saikosaponin F circulating in the ileum for 120 min were significantly decreased (P<0.05). CONCLUSIONS Saikosaponin A and the other 4 saikosaponins are all absorbed in the duodenum, jejunum and ileum; among them, saikosaponin A, B2, C and F are linearly absorbed, which conforms to the zero-order absorption characteristics, but saikosaponin D shows non- linear absorption.